Keith Crandell - 08 Feb 2022 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ William Solis, as Attorney-in-Fact for Keith Crandell
Issuer symbol
TWST
Transactions as of
08 Feb 2022
Transactions value $
$0
Form type
4
Filing time
10 Feb 2022, 18:32:57
Previous filing
05 Jan 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +3.49K +718.31% $0.00 3.98K 08 Feb 2022 Direct F1
holding TWST Common Stock 76K 08 Feb 2022 By Keith L. Crandell Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Shares subject to the Annual Equity Award will vest upon the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the first annual meeting of stockholders following the date of grant, provided that the Non-Employee Director is a Service Provider on each vesting date.